生命科学资讯

How Mirum is Advancing Rare Disease Care Through Strategic M&A

Monash Innovation Labs and Agilent partner to strengthen applied research in Australia - BioSpectrum Asia

Thermo Fisher Scientific (TMO) Is Down 7.2% After Stronger‑Than‑Expected 2025 Earnings Beat Expectations - What's Changed - simplywall.st

Agilent Technologies, Inc. (A) Stock Analysis: Potential 26.76% Upside Raises Investor Optimism - DirectorsTalk Interviews

Deutsche Bank Maintains Buy on Lonza Group AG (LZAGY) Feb 2026 - Meyka

Waters Corporation (WAT): A Bull Case Theory - Insider Monkey

Waters Corporation (WAT): A Bull Case Theory - Finviz

Novo’s CagriSema tops semaglutide in ph. 3 diabetes study

Carbon Health files for bankruptcy, seeking to sell or restructure

Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - FinancialContent

First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?

GSK gives back rights to Wave's genetic disease RNA editor

Thermo Fisher trims Massachusetts headcount with Franklin site closure

GSK plans to lay off up to 350 R&D workers across US, UK

Thermo Fisher to close Franklin site, impacting up to 80 workers - Boston.com

Thermo Fisher to close Franklin site, affecting up to 80 workers - Boston.com

New CagriSema data show improvement over semaglutide

Novo combination obesity shot meets goal in diabetes trial

UPC Clarifies PI Costs Breakdown In mRNA Fight - Law360

Thermo Fisher trims Massachusetts headcount with Franklin site closure - Fierce Pharma